In the aforementioned pathway, TGFβ interactions with CXCR4 shift HCC cells towards a mesenchymal phenotype (88) and increase invasiveness when treated with exogenous CXCL12 (89). Here, TGFB1 is linked to hepatocellular carcinoma.